Patents by Inventor Jena Steinle

Jena Steinle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for regulating retinal endothelial cell viability
    Patent number: 10010516
    Abstract: Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a quinic acid analog. The method may be applied to prevent, treat or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy and chemotherapy for retinoblastoma.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: July 3, 2018
    Assignee: The University of Tennessee Research Foundation
    Inventors: Charles Ryan Yates, Jena Steinle Smith, Duane Douglas Miller, Jordan J. Toutounchian
  • Method for regulating retinal endothelial cell viability
    Patent number: 9566255
    Abstract: Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a quinic acid analog. The method may be applied to prevent, treat or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy and chemotherapy for retinoblastoma.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: February 14, 2017
    Assignee: The University of Tennessee Research Foundation
    Inventors: Charles Ryan Yates, Jena Steinle Smith, Duane Douglas Miller, Jordan J. Toutounchian
  • METHOD FOR REGULATING RETINAL ENDOTHELIAL CELL VIABILITY
    Publication number: 20140094518
    Abstract: Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a quinic acid analog. The method may be applied to prevent, treat or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy and chemotherapy for retinoblastoma.
    Type: Application
    Filed: November 7, 2013
    Publication date: April 3, 2014
    Applicant: The University of Tennessee Research Foundation
    Inventors: Charles Ryan Yates, Jena Steinle Smith, Duane Douglas Miller, Jordan J. Toutounchian
  • Methods and materials for treating retinopathy
    Publication number: 20070112076
    Abstract: The present invention is directed to topical ophthalmic compositions and methods for treating retinopathy.
    Type: Application
    Filed: November 15, 2006
    Publication date: May 17, 2007
    Applicant: SOUTHERN ILLINOIS UNIVERSITY
    Inventor: Jena Steinle